Hallmarq has been acquired by NORD Holding

Arrowpoint Advisory’s Healthcare sector team has advised the shareholders of Hallmarq Veterinary Imaging (“Hallmarq”) on its sale to NORD Holding, to support a strategic combination of Hallmarq and OR Technology to form a global multimodality imaging group.

Hallmarq Veterinary Imaging is a global leader in advanced diagnostic imaging solutions designed specifically for veterinary practice. Founded in 2001, Hallmarq has pioneered species-specific MRI and CT technologies, starting with the world’s first standing MRI for horses and extending to zero-helium small animal 1.5T MRI and Vision CT systems that enhance diagnostic accuracy, speed and accessibility for equine and small animal care.

With more than 200 employees across Europe, MEA and North America, the group brings together Hallmarq’s leading expertise and innovation in veterinary MRI and CT technologies and OR Technology’s established multimodality portfolio for companion animals and equine patients including digital X-ray, ultrasound, and CT imaging. The combination creates a unique platform spanning a wide range of imaging modalities, software solutions including AI-supported diagnostics, clinical applications, and customer segments, positioning the group as a global leader in veterinary diagnostic imaging.

Together, OR Technology and Hallmarq are setting the foundation for a strong, globally active imaging group—committed to advancing diagnostic imaging and improving clinical outcomes in veterinary and human medicine.

André Seidel, Partner at NORD Holding, commented: “This combination represents another important step in the development of our investment. Bringing together complementary technologies, strong innovation capabilities, and international reach provides an excellent foundation for building a global leader in multimodality veterinary imaging.”

Mick Crosthwaite, CEO at Hallmarq, stated: “Joining forces, allows us to deliver even greater value to our customers with the scale, expertise and ambition to redefine what’s possible in veterinary diagnostic imaging. The combination creates a unique platform spanning a wide range of imaging modalities, software solutions including AI-supported diagnostics, clinical applications, and customer segments, positioning the group as a global leader in veterinary diagnostic imaging.”

David Lonsdale, Managing Partner at August Equity, said: “The support and guidance we received from Karen and the team throughout the Hallmarq transaction was exceptional. The team quickly understood our priorities, brought real sector insight, and provided calm, pragmatic advice at every stage. Their commitment, professionalism, and ability to navigate complexity were instrumental in achieving the right outcome for all stakeholders.”

Peter Fredericks, Group CEO at Hallmarq, highlighted: “Karen and her team were an invaluable asset to us throughout our process. Much of the heavy lifting was provided by them leaving me to dedicate more of my bandwidth to the commercial and technical aspects of the sale. And always delivered with a smile.”

Karen Dawaf, Managing Director at Arrowpoint Advisory concluded: “It has been a pleasure to work alongside August Equity and the Hallmarq team on this important milestone for the business. The combination of Hallmarq’s market‑leading imaging technology and OR Technology, backed by NORD Holding, creates a compelling platform for continued innovation and global growth. We wish Mick and Peter every success in this next chapter.”

Contact the deal team

DISCOVER our sell-side transactions